Peter U Fischer
Overview
Explore the profile of Peter U Fischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
1676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tobon Ramos J, Maure T, Carias L, Lew D, Goss C, Samuel A, et al.
PLoS Negl Trop Dis
. 2025 Mar;
19(3):e0012851.
PMID: 40063867
Background: Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF...
2.
Bun K, Mode B, Susapu M, Salo J, Bjerum C, Payne M, et al.
PLoS Negl Trop Dis
. 2025 Jan;
19(1):e0012128.
PMID: 39869653
Background: WHO recommends two annual rounds of mass drug administration (MDA) with ivermectin, diethylcarbamazine, and albendazole (IDA) for lymphatic filariasis (LF) elimination in treatment naïve areas that are not co-endemic...
3.
Yates D, Di Maggio L, Rosa B, Sprung R, Erdmann-Gilmore P, Townsend R, et al.
Front Parasitol
. 2025 Jan;
2():1281092.
PMID: 39816829
Background: Improved diagnostic tools are needed for detecting active filarial infections in humans. Tests are available that detect adult circulating filarial antigen, but there are no sensitive and specific biomarker...
4.
Di Maggio L, Fischer K, Rosa B, Yates D, Cho B, Lukowski J, et al.
bioRxiv
. 2024 Oct;
PMID: 39463952
is the agent of onchocerciasis (river blindness) and targeted by WHO for elimination though mass drug administration with ivermectin. A small percentage of adult worms develop pleomorphic neoplasms (PN) that...
5.
Greene S, Huang Y, Fischer K, Rosa B, Martin J, Mitreva M, et al.
PLoS Negl Trop Dis
. 2024 Sep;
18(9):e0012461.
PMID: 39226306
Background: Loiasis is a disease caused by the nematode Loa loa. Serious adverse events sometimes occur in people with heavy L. loa microfilaremia after ivermectin treatment. In regions of Central...
6.
Risch F, Kazakov A, Specht S, Pfarr K, Fischer P, Hoerauf A, et al.
Trends Parasitol
. 2024 Aug;
40(9):829-845.
PMID: 39122645
Although lymphatic filariasis and onchocerciasis have been targeted for global elimination, these helminth infections are still a major public health problem across the tropics and subtropics. Despite decades of research,...
7.
Choi Y, Fischer K, Meite A, Koudou B, Fischer P, Mitreva M
EBioMedicine
. 2024 Jun;
105:105188.
PMID: 38848649
Background: The Global Program to Eliminate Lymphatic Filariasis (GPELF) is the largest public health program based on mass drug administration (MDA). Despite decades of MDA, ongoing transmission in some countries...
8.
Doherty M, Grant J, Pilotte N, Bennuru S, Fischer K, Fischer P, et al.
PLoS Negl Trop Dis
. 2023 Dec;
17(12):e0011815.
PMID: 38096317
Background: Onchocerca volvulus is a filarial parasite that is a major cause of dermatitis and blindness in endemic regions primarily in sub-Saharan Africa. Widespread efforts to control the disease caused...
9.
Supali T, Djuardi Y, Sianipar L, Suryaningtyas N, Alfian R, Destani Y, et al.
Am J Trop Med Hyg
. 2023 Nov;
110(1):111-116.
PMID: 38011734
Brugia malayi is the major cause of lymphatic filariasis (LF) in Indonesia. Zoophilic B. malayi was endemic in Belitung district, and mass drug administration (MDA) with diethylcarbamazine (DEC) and albendazole...
10.
Choi Y, Fischer K, Meite A, Koudou B, Fischer P, Mitreva M
medRxiv
. 2023 Nov;
PMID: 37986785
Background: The Global Program to Eliminate Lymphatic Filariasis is the largest public health program based on mass drug administration (MDA). Despite decades of MDA, ongoing transmission in some countries remains...